COMMUNIQUÉS West-GlobeNewswire

Reata Pharmaceuticals, Inc. to Report Second Quarter 2018 Financial Results and an Update on Development Programs on Wednesday, August 8, 2018
06/08/2018
IRVING, Texas, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and live webcast on [...]
Maidstone and Tunbridge Wells NHS Trust selects Allscripts Sunrise
06/08/2018
Existing patient administration system customer strengthens its relationship with Allscripts by choosing it as its electronic health record partner; boosting the company’s position in the Kent healthcare community [...]
Zogenix Announces Proposed Public Offering of 6,000,000 Shares of Common Stock
06/08/2018
EMERYVILLE, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, announced today [...]
PRA Health Sciences, Inc. Announces Secondary Offering of 6,500,000 Shares of Common Stock
06/08/2018
RALEIGH, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that an affiliate of, or a fund sponsored by, Kohlberg Kravis Roberts & Co. (the “Selling [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Syneos Health Announces Secondary Offering of Common Stock
06/08/2018
RALEIGH, N.C., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), a leading biopharmaceutical solutions organization combining a CRO (Contract Research Organization [...]
Antares Pharma Appoints Dr. James Tursi Executive Vice President, Head of Research & Development, Chief Medical Officer
06/08/2018
EWING, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of James P. Tursi M.D. to the position of Executive Vice President, Head of Research & Development, [...]
AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry®
06/08/2018
WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has closed the previously announced divestiture of Cord Blood Registry (CBR®) to GI Partners, a private [...]
Zogenix Provides Corporate Update and Reports Second Quarter Financial Results
06/08/2018
Reported positive top-line results from second pivotal Phase 3 trial of ZX008 in patients with Dravet syndrome, Study 1504 Submission of U.S. and EU regulatory filings for ZX008 in Dravet syndrome anticipated by year- [...]
NeoGenomics Announces Proposed Public Offering of Common Stock
06/08/2018
FT. MYERS, Fla., Aug. 06, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has commenced an underwritten public offering of [...]
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
06/08/2018
CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Neon Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights
06/08/2018
– Successfully completed initial public offering, raising $100 million in gross proceeds – – Significant progress across platform and portfolio of vaccine and T-cell programs – – Enrollment completed for NEO-PV-01 for [...]
Fulgent Genetics Reports Second Quarter 2018 Financial Results
06/08/2018
Second Quarter 2018 Results : Revenue totals $5.4 million, growing 16% year over year and 16% sequentially Billable tests delivered total 5,700, growing 47% year over year and 23% sequentially GAAP and non-GAAP gross [...]
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]
Kura Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update
06/08/2018
– Update from ongoing Phase 2 trial of tipifarnib in HRAS mutant head and neck squamous cell carcinomas (HNSCC) to be presented at ESMO 2018 – – Startup activities initiated for upcoming registration-directed trial of [...]
Akcea Reports Financial Results and Highlights for Second Quarter 2018
06/08/2018
TEGSEDI™ (inotersen) Approved in European Union $382 million to fund the company through key milestones in 2019 Conference Call Webcast Monday, August 6, 4:30 p.m. ET at www.akceatx.com CAMBRIDGE, Mass., Aug. 06, 2018 ( [...]
Editas Medicine Announces Second Quarter 2018 Results and Update
06/08/2018
Allergan exercises option to develop and commercialize EDIT-101 globally and Editas exercises option to co-develop and equally share profits and losses in the United States Plan to file EDIT-101 Investigational New Drug [...]
Vericel Reports Record Second Quarter Revenues of $19.0 Million and Raises Full Year 2018 Revenue Guidance
06/08/2018
Conference Call Today at 4:30pm Eastern Time CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care [...]
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
06/08/2018
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq:ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic [...]

Pages